LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 - Amendment to Purchase & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 02 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
3,041,564 |
2.36% |
609,540 |
0.47% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
285,211 |
0.22% |
739,005 |
0.57% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
3,326,775 |
2.58% |
1,348,545 |
1.05% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
2 |
214.7200 USD |
Purchase |
13 |
212.7169 USD |
Purchase |
14 |
212.5019 USD |
Purchase |
15 |
213.1110 USD |
Purchase |
16 |
213.0581 USD |
Purchase |
18 |
212.9719 USD |
Purchase |
18 |
212.9716 USD |
Purchase |
20 |
213.1620 USD |
Purchase |
21 |
212.9478 USD |
Purchase |
21 |
215.2100 USD |
Purchase |
22 |
212.5909 USD |
Purchase |
23 |
213.0128 USD |
Purchase |
27 |
212.9100 USD |
Purchase |
31 |
213.1153 USD |
Purchase |
60 |
213.6800 USD |
Purchase |
92 |
212.4150 USD |
Purchase |
100 |
212.3700 USD |
Purchase |
100 |
213.9200 USD |
Purchase |
115 |
215.3223 USD |
Purchase |
120 |
215.2766 USD |
Purchase |
126 |
212.7595 USD |
Purchase |
141 |
212.4093 USD |
Purchase |
222 |
211.9675 USD |
Purchase |
230 |
212.5527 USD |
Purchase |
238 |
212.9391 USD |
Purchase |
239 |
213.6813 USD |
Purchase |
258 |
212.5341 USD |
Purchase |
267 |
215.2318 USD |
Purchase |
272 |
212.7394 USD |
Purchase |
288 |
213.0338 USD |
Purchase |
384 |
212.8770 USD |
Purchase |
396 |
213.5560 USD |
Purchase |
400 |
212.9316 USD |
Purchase |
416 |
212.8180 USD |
Purchase |
517 |
212.8305 USD |
Purchase |
517 |
215.3776 USD |
Purchase |
574 |
215.4842 USD |
Purchase |
685 |
212.5865 USD |
Purchase |
1,075 |
212.6502 USD |
Purchase |
1,171 |
215.2917 USD |
Purchase |
2,260 |
212.6221 USD |
Purchase |
4,106 |
212.6730 USD |
Purchase |
4,463 |
212.8202 USD |
Purchase |
4,565 |
212.5250 USD |
Purchase |
7,775 |
212.4900 USD |
Purchase |
15,662 |
212.9133 USD |
Sale |
1 |
214.5200 USD |
Sale |
1 |
212.5400 USD |
Sale |
1 |
215.2800 USD |
Sale |
3 |
213.7550 USD |
Sale |
7 |
212.3900 USD |
Sale |
7 |
212.9685 USD |
Sale |
9 |
212.7866 USD |
Sale |
10 |
212.9200 USD |
Sale |
72 |
215.0800 USD |
Sale |
123 |
212.5534 USD |
Sale |
132 |
212.2248 USD |
Sale |
200 |
214.1800 USD |
Sale |
201 |
212.5101 USD |
Sale |
210 |
215.3076 USD |
Sale |
393 |
212.5205 USD |
Sale |
476 |
212.9391 USD |
Sale |
478 |
212.9700 USD |
Sale |
685 |
212.5865 USD |
Sale |
1,049 |
213.3874 USD |
Sale |
1,669 |
212.4897 USD |
Sale |
2,376 |
212.7322 USD |
Sale |
2,785 |
215.3416 USD |
Sale |
2,797 |
212.9479 USD |
Sale |
3,420 |
212.6453 USD |
Sale |
4,288 |
212.6370 USD |
Sale |
6,000 |
212.7315 USD |
Sale |
6,291 |
212.4900 USD |
Sale |
12,932 |
212.8323 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing |
and any other person relating to the voting rights of any relevant securities under any option |
referred to on this form or relating to the voting rights or future acquisition or disposal of any |
relevant securities to which any derivative referred to on this form is referenced. If none, this |
should be stated. |
NONE |
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 7 Dec 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |